4//SEC Filing
Syndax Pharmaceuticals Inc 4
Accession 0001562180-17-000692
$SNDXCIK 0001395937operating
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 10:32 AM ET
Size
5.7 KB
Accession
0001562180-17-000692
Insider Transaction Report
Form 4
Shea Richard P
Director
Transactions
- Award
Stock Option (Right to Buy)
2017-02-13+125,000→ 125,000 totalExercise: $10.20Exp: 2027-02-13→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the total number of shares underlying the option shall vest on February 13, 2018, and one forty-eighth (1/48th) of the total number of shares underlying the option shall vest monthly thereafter on the last day of each month, subject to the reporting person's continuous service on the relevant vesting dates.
Documents
Issuer
Syndax Pharmaceuticals Inc
CIK 0001395937
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001395937
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 10:32 AM ET
- Size
- 5.7 KB